Healthcare Distribution Market by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Healthcare Distribution market size is expected to hit around USD 4.2 Trillion by 2030 from valued at USD 879.3 billion in 2021 and growing at a CAGR of 25.2% from 2022 to 2030.

The growth of this market is primarily driven by the rising incidence of chronic diseases, growing importance of generics, rising adoption of track & trace solutions, and the growth of the medical device industry. In addition, emerging markets such as China and India, growth in the biosimilars market, increasing specialty drug dispensing, and increasing uptake of biopharmaceuticals are expected to offer potential growth opportunities to market players in the coming years. However, the increasing pricing pressure on market players is a major factor that is expected to impact market growth in the coming years.

Report Scope of the Healthcare Distribution Market

COVID-19 Impact on Healthcare Distribution Market

In this situation of COVID19 this market is only one market which is growing tremendously. Because the threat of this pandemic the world is expecting the better medicines and the most need is covid 19 vaccines. This market is growing in such a way that the players of other sectors are trying to establish in this market.

Market Drivers

The high incidence and large economic crises of chronic disease are primarily driving the market growth, high investments in R&D activities and increasing launch of new rugs and medicines in the healthcare market is supporting the growth of the distribution market.

The technological advancements along with the subsequent growth in track and trace solution in the healthcare distribution industry are further contributing to the growth of the market.

Market Opportunities

The market is gaining pace due to increase in usage of generics in the healthcare sector. Moreover the growing medical device industry is further boosting the demand in the market

The growing biosimilar markets in emerging economics is likely to create potential demands over the period.

The U.S. Market is Estimated at $385 Billion, While China is Forecast to Grow at 24.2% CAGR

The Healthcare Distribution market in the U.S. is estimated at US$385 Billion in the year 2021. China, the world's second largest economy, is forecast to reach a projected market size of US$761.3 Billion by the year 2030 trailing a CAGR of 24.2% over the period 2020 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 20.1% and 22.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 22.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$399.3 Billion by the year 2030.

The pharmaceutical product distribution services segment dominated the healthcare distribution market in 2021

On the basis of type, the healthcare distribution market is segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In 2018, the pharmaceutical product distribution services segment accounted for the largest share of the market majorly due to the increasing production of pharmaceutical formulations, rising pharmaceutical R&D expenditure, outsourcing of pharmaceutical manufacturing to Asian countries, and the establishment of new manufacturing facilitates by global pharmaceutical giants in newer geographies.

Retail pharmacies to account for the largest share of the healthcare distribution market, by end user, in 2021

On the basis of end user, the healthcare distribution market is segmented into retail pharmacies, hospital pharmacies, and other end users. The retail pharmacies segment accounted for the largest share of the market in 2018. These pharmacies deal with a large volume of prescriptions on a daily basis. Moreover, in the US and other developed countries, the implementation of programs to ensure affordable healthcare for citizens has significantly increased the volume of prescriptions in retail pharmacies.

APAC market to grow at the highest CAGR during the forecast period

North America dominated the healthcare distribution market in 2018. However, the APAC market is estimated to grow at the highest CAGR during the forecast period owing to the growing regulatory requirements in the healthcare industries of several APAC countries to maintain compliance with good manufacturing and distribution practices and the rising number of pharmaceutical and biotechnology companies in this region. China and India are the fastest-growing markets in this region majorly due to the expanding pharmaceutical industries in these countries and the implementation of stringent regulations to enhance the quality and reliability of pharmaceutical drugs.

Some of the prominent players in the Healthcare Distribution Market include:

 McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor, Inc. (US), Morris and Dickson Co., LLC (US), KeySource Medical, Inc. (US), Rochester Drug Cooperative, Inc. (US), Henry Schein Inc. (US), Smith Drug Company (US), FFF Enterprises (US), Patterson Companies Inc. (US), Mutual Drug (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Medline Industries (US), PHOENIX Group (Germany), and CuraScript SD (US).

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Healthcare Distribution market

Healthcare Distribution Market, by Type

• Pharmaceutical Product Distribution Services
• OTC Drugs/Vitamins
• Generic Drugs
• Brand-name/Innovator Drugs
• Biopharmaceutical Product Distribution Services
• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Blood and Blood Products
• Other Products (cellular & gene therapy products, stem cell products, and tissue & tissue products)
• Medical Device Distribution Services

Healthcare Distribution Market, by End User

• Retail Pharmacies
• Hospital Pharmacies
• Other End Users (clinical laboratories, physician offices, home care settings, online pharmacies, and long-term care facilities)

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Healthcare Distribution industry analysis from 2022 to 2030 to identify the prevailing Healthcare Distribution industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Healthcare Distribution industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Healthcare Distribution industry trends, key players, market segments, application areas, and market growth strategies.